Narrow search
Showing 1 - 10 of 132
Cover Image
Response to Baker and Fugh-Berman's critique of my paper, "Why has longevity increased more in some states than in others?"
Lichtenberg, Frank R. - 2009
longevity increased more in some states than in others?ʺ One of the conclusions I drew from that study was that medical … smoking in the analysis of longevity. In this article, I make the case that their claims about my study are largely incorrect …. Controlling for the age distribution of the population also has essentially no effect on the longevity equation estimates. I argue …
Persistent link: https://www.econbiz.de/10003861794
Cover Image
Spurious correlation in estimation of the health production function : a note
Akkoyunlu, Sule; Lichtenberg, Frank R.; Siliverstovs, Boriss - 2009
contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health … care expenditure. The results of the bounds testing procedure show longevity to be linearly related to these two factors …
Persistent link: https://www.econbiz.de/10003900852
Cover Image
Spurious correlation in estimation of the health production function : a note
Akkoyunlu, Sule; Lichtenberg, Frank R.; Siliverstovs, Boriss - 2009
contribution by Lichtenberg (2004), which relates longevity in the United States to pharmaceutical innovation and public health … care expenditure. The results of the bounds testing procedure show longevity to be linearly related to these two factors …
Persistent link: https://www.econbiz.de/10003909500
Cover Image
Impact of specialization on health outcomes : evidence from U.S. cancer data
Schoder, Johannes; Lichtenberg, Frank R. - 2010
There have been many studies of the volume-outcome relationship. In all of these, the unit of analysis is the hospital or physician. However, this level of analysis is mostly limited to the use of in-hospital mortality rates and is particularly sensitive to selective referral. Moreover, the...
Persistent link: https://www.econbiz.de/10008695986
Cover Image
The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010 : evidence from longitudinal, disease-level data
Lichtenberg, Frank R.; Pettersson, Billie - 2012
We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical … estimated to have increased mean age at death by 0.60 years during the period. The estimates indicate that longevity depends on … utilization in Sweden, so the cost per life-year gained from the introduction of new drugs was quite low. -- longevity …
Persistent link: https://www.econbiz.de/10009571756
Cover Image
The impact of recent chemotherapy innovation on the longevity of Myeloma patients : U.S. and international evidence
Lichtenberg, Frank R.; Hostenkamp, Gisela - 2013
important innovations since 1997. We investigate the impact of recent chemotherapy innovation on the longevity of myeloma …
Persistent link: https://www.econbiz.de/10010223067
Cover Image
The Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France
Lichtenberg, Frank R. - 2014
I investigate the contribution of pharmaceutical innovation to recent longevity growth in Germany and France. First, I …
Persistent link: https://www.econbiz.de/10013069689
Cover Image
Response to Baker and Fugh-Berman's Critique of My Paper, 'Why Has Longevity Increased More in Some States than in Others?'
Lichtenberg, Frank R. - 2009
longevity increased more in some states than in others?” One of the conclusions I drew from that study was that medical … smoking in the analysis of longevity. In this article, I make the case that their claims about my study are largely incorrect …. Controlling for the age distribution of the population also has essentially no effect on the longevity equation estimates. I argue …
Persistent link: https://www.econbiz.de/10013157847
Cover Image
Pharmaceuticai Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010
Lichtenberg, Frank R. - 2021
Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months) — about 44% of the total increase in longevity …
Persistent link: https://www.econbiz.de/10013315556
Cover Image
The Impact of Recent Chemotherapy Innovation on the Longevity of Myeloma Patients : U.S. and International Evidence
Lichtenberg, Frank R.; Hostenkamp, Gisela - 2021
important innovations since 1997. We investigate the impact of recent chemotherapy innovation on the longevity of myeloma …
Persistent link: https://www.econbiz.de/10013315665